TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an update.
Tong Ren Tang Technologies Co has renewed its Land Use Right Leasing Agreement with Tong Ren Tang Holdings, extending the lease for an additional three years from October 2025 to October 2028. This renewal allows the company to continue its operations at a prime location in Beijing, which is crucial for its business activities and development. The agreement is seen as beneficial due to the stable lease terms and cost savings from avoiding relocation, aligning with the company’s strategic interests and supporting its future business needs.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is primarily focused on producing and distributing traditional Chinese medicine products.
Average Trading Volume: 1,198,362
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.05B
For detailed information about 1666 stock, go to TipRanks’ Stock Analysis page.